During the past decade, S.C Policlinica CCBR S.R.L conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 4 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 2 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "S.C Policlinica CCBR S.R.L" #1 collaborator was "Novartis" with 3 trials as a collaborator, "Arena is a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator and "Brigham and Women's Hospital" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "S.C Policlinica CCBR S.R.L" are "Cardiovascular Disease" (2 trials), "Osteoarthritis" (2 trials), "Ulcerative Colitis" (2 trials), "Crohn's Disease" (1 trials) and "Dyslipidemia" (1 trials). Many other conditions were trialed in "S.C Policlinica CCBR S.R.L" in a lesser frequency.

Most popular intervention types in "S.C Policlinica CCBR S.R.L" are "Drug" (9 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Etrasimod" (3 trials), "SMC021 Placebo" (2 trials), "bococizumab (PF-04950615)" (2 trials) and "K-877" (1 trials). Other intervention names were less common.

The vast majority of trials in "S.C Policlinica CCBR S.R.L" are 8 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "S.C Policlinica CCBR S.R.L". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in S.C Policlinica CCBR S.R.L, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in S.C Policlinica CCBR S.R.L, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".